XLP

Clinical trials for XLP explained in plain language.

Never miss a new study

Get alerted when new XLP trials appear

Sign up with your email to follow new studies for XLP, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New drug aims to let Sun-Sensitive patients enjoy daylight

Symptom relief Completed

This study tested whether an investigational drug called MT-7117 could help people with erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP). These conditions cause severe burning, tingling, or stinging pain soon after sunlight exposure. The trial involved 184 par…

Matched conditions: XLP

Phase: PHASE3 • Sponsor: Tanabe Pharma America, Inc. • Aim: Symptom relief

Last updated Mar 13, 2026 15:05 UTC

XLP

Get alerted when new XLP trials appear

New drug aims to let Sun-Sensitive patients enjoy daylight